NCT00000970View on ClinicalTrials.gov

A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1993

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Foscarnet sodium

DRUG

Ganciclovir

Trial Locations (6)

10021

Memorial Sloan-Kettering Cancer Ctr., New York

27599

Unc Aids Crs, Chapel Hill

90033

USC CRS, Los Angeles

98122

University of Washington AIDS CRS, Seattle

Unknown

Ucsf Aids Crs, San Francisco

Washington U CRS, St Louis

Sponsors

Collaborators (1)

Astra USA
All Listed Sponsors
collaborator

Astra USA

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000970 - A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir | Biotech Hunter | Biotech Hunter